Denis Dufresne has over 25 years of experience in representing public (Nasdaq and NYSE, including post-deSPAC companies) and private companies, investment funds and lending institutions, and high net worth individuals on complex business transactions and personal matters. His clients include founders, entrepreneurs, athletes, entertainers, emerging and established entities, independent members of public company boards, borrowers, lenders, placement agents and underwriters.

In Mr. Dufresne’s public company experience he counsels his public company clients in connection with ’33 Act and ’34 Act matters, regularly advises boards of directors and board committees and assists in all shareholder matters including annual and special shareholder meetings.

His mergers and acquisitions transactional practice is across industry and includes a deep representation in the area of life sciences, where his background includes a broad experience in the full range of licensing and collaboration, structured M&A and other transactions common to this sector. In his M&A practice, Mr. Dufresne routinely assists his public and private company clients in structuring, negotiating, documenting, and executing acquisitions and divestitures of businesses and assets (including licensing arrangements), leveraged buyouts, business combinations, equity and debt investments, debt restructuring, joint ventures and other individualized and commercial transactions.